inflammatory bowel diseases
Scope
Date
~
-
Pharmaceuticals
TiumBio acquires stake in SK Plasma to beef up R&D for rare diseases
South Korea-based biopharmaceutical company TiumBio is set to acquire 30 billion won ($26 million) worth of shares in SK Plasma, a blood product com...
Jul 28, 2021 (Gmt+09:00)
-
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
Bio
Celltrion to co-develop pill-type autoimmune disease drug with UK startup
Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...
Aug 20, 2020 (Gmt+09:00)